Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Pathology

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/ajpath.2008.070726PMID 18202187PMCID PMC2312353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitric oxide is an important mediator of renal tubular epithelial cell death in vitro and in murine experimental hydronephrosis.

  2006cited by this paper
• Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor

  2006cited by this paper
• Galectin-3 regulates myofibroblast activation and hepatic fibrosis.

  2006cited by this paper
• Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis

  2006cited by this paper
• C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions.

  2005cited by this paper
• Adoptive transfer of macrophages ameliorates renal fibrosis in mice.

  2005cited by this paper
• Chronic kidney disease: the global challenge

  2005cited by this paper
• Conditional Macrophage Ablation Demonstrates That Resident Macrophages Initiate Acute Peritoneal Inflammation1

  2005cited by this paper
• Conditional ablation of macrophages halts progression of crescentic glomerulonephritis.

  2005cited by this paper
• Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

  2005cited by this paper
• Obstructive nephropathy: insights from genetically engineered animals.

  2005cited by this paper
• Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction

  2004cited by this paper
• Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction.

  2004cited by this paper
• Blockade of CCR2 ameliorates progressive fibrosis in kidney.

  2004cited by this paper
• Transplantation 50 years later--progress, challenges, and promises.

  2004cited by this paper
• Stimulation of Proliferation of Rat Hepatic Stellate Cells by Galectin-1 and Galectin-3 through Different Intracellular Signaling Pathways*

  2003cited by this paper
• Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

  2003cited by this paper
• Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation.

  2003cited by this paper
• Stimulation of proliferation of hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways

  2003cited by this paper
• BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury

  2003cited by this paper
• Fibrocytes: a unique cell population implicated in wound healing

  2003cited by this paper
• Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.

  2003cited by this paper
• Transforming Growth Factor-β-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in β6−/− Mice

  2003cited by this paper
• Obstructive Uropathy: An Important Cause of Chronic Renal Failure in Children

  2002cited by this paper
• Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice.

  2002cited by this paper
• A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.

  2002cited by this paper
• Evidence that fibroblasts derive from epithelium during tissue fibrosis.

  2002cited by this paper
• Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.

  2002cited by this paper
• The role of tubulointerstitial injury in chronic renal failure.

  2000cited by this paper
• Maturation of human monocyte-derived dendritic cells studied by microarray hybridization.

  2000cited by this paper
• Activated Macrophages Direct Apoptosis and Suppress Mitosis of Mesangial Cells1

  2000cited by this paper
• Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis.

  1999cited by this paper
• Galectin‐3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti‐Thy1.1 antibodies

  1999cited by this paper
• Role of Fas (CD95) in tubulointerstitial disease induced by unilateral ureteric obstruction.

  1999cited by this paper
• Galectin-3 stimulates cell proliferation.

  1998cited by this paper
• Maintenance of granulocyte numbers during acute peritonitis is defective in galectin‐3‐null mutant mice

  1998cited by this paper
• Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes.

  1998cited by this paper
• TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

  1997cited by this paper
• TGF-β signalling from cell membrane to nucleus through SMAD proteins

  1997cited by this paper
• Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides.

  1996cited by this paper
• Myofibroblasts in experimental hydronephrosis.

  1995cited by this paper
• Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages.

  1995cited by this paper
• Macrophages and progressive renal disease in experimental hydronephrosis.

  1995cited by this paper
• Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages.

  1994cited by this paper
• The emerging role of transforming growth factor-beta in kidney diseases.

  1994cited by this paper
• Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: role of macrophages.

  1991cited by this paper
• Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney.

  1988cited by this paper
• Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts.

  1987cited by this paper
• Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.

  1982cited by this paper
• A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro.

  1976cited by this paper
• The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum.

  1975cited by this paper

• Cardiac macrophages across space and time: Roles in homeostasis, disease, and remodeling.

  2026cites this paper
• The response to kidney injury is epigenetically regulated through the activation of bivalent genes.

  2026cites this paper
• Interleukin-6 blockade modulates monocyte recruitment to protect against diastolic dysfunction associated with inflammatory arthritis

  2026cites this paper
• ADAM17 Deletion Protects Against Type1 Diabetes-Associated Kidney Injury by Modulating Inflammatory and Fibrotic Pathways

  2026cites this paper
• The Role of Galectin-3 in Liver Inflammation and Fibrosis

  2026cites this paper
• Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease

  2025cites this paper
• CD38hi macrophages promote fibrotic transition following acute kidney injury by modulating NAD+ metabolism.

  2025cites this paper
• Galectin-3 is a Nanotherapeutic Target in Graft-versus-Host Disease Mediated Kidney Injury

  2025cites this paper
• Galectin-3/CD146 interaction promotes renal damage and systemic inflammation after acute kidney injury

  2025cites this paper
• Structural immunity: immune cells as architects of tissue barriers.

  2025cites this paper
• Model Systems of Chronic Kidney Disease: A Detailed Overview and Recent Advances

  2025cites this paper
• Evaluation of serum galectin-3 concentrations in healthy cats and in cats with ureteral obstruction

  2025cites this paper
• Immune microenvironment in autosomal dominant polycystic kidney disease

  2025cites this paper
• Crosstalk between macrophages and adjacent cells in AKI to CKD transition

  2025cites this paper
• High Levels of Galectin-3 and Uric Acid Are Independent Predictors of Renal Impairment in Patients with Stable Coronary Artery Disease

  2025cites this paper
• Modified citrus pectin ameliorates methotrexate-induced hepatic and pulmonary toxicity: role of Nrf2, galectin-3/TLR-4/NF-κB/TNF-α and TGF-β signaling pathways

  2025cites this paper
• Discovery of Galactopyranose‐1‐carboxamides as a New Class of Small, Novel, Potent, Selective, and Orally Active Galectin‐3 Inhibitors

  2025cites this paper
• Advances and challenges in kidney fibrosis therapeutics

  2025cites this paper
• Integrated multi-omics analysis of renal metabolism in domestic cats with spontaneous chronic kidney disease

  2025cites this paper
• Dissecting the specificity of sugar code recognition - Unleashing the biomedical potential of galectins by protein engineering.

  2025cites this paper
• Predictive value of interstitial inflammation for renal outcome in patients with immunoglobulin a nephropathy.

  2025cites this paper
• Galectin-3: Heart failure biomarker in pediatric heart defects

  2025cites this paper
• Macrophage Zc3h12c Limits Tissue Inflammation and Injury via Alternative Splicing of Pre‐mRNA

  2025cites this paper
• Endogenous Galectin-8 protects against Th17 infiltration and fibrosis following acute kidney injury

  2025cites this paper
• Loss of ALK4 promotes cancer progression through regulating TGF-β receptor N-glycosylation

  2025cites this paper
• Profibrotic impact of PAD4-driven macrophage extracellular traps in ulcerative colitis.

  2025cites this paper
• Association between serum uric acid levels and galectin‐3 in patients with uncomplicated type 2 diabetes

  2025cites this paper
• Targeting the Glial Scar: Biomaterial and Drug-Based Strategies for Modulation In Vitro.

  2025cites this paper
• Macrophage Derived Galectin‐3 Promotes Renal Fibrosis and Diabetic Kidney Disease by Enhancing TGFβ1 Signaling

  2025cites this paper
• Targeting Galectin-3 to modulate inflammation in LAMA2-deficient congenital muscular dystrophy

  2025cites this paper
• Cigarette smoke-induced galectin-3 as a diagnostic biomarker and therapeutic target in lung tissue remodeling.

  2024cites this paper
• Novel Biomarkers in Evaluating Cardiac Function in Patients on Hemodialysis—A Pilot Prospective Observational Cohort Study

  2024cites this paper
• The pathogenic role of succinate-SUCNR1: a critical function that induces renal fibrosis via M2 macrophage

  2024cites this paper
• Oligonucleotide therapies for nonalcoholic steatohepatitis

  2024cites this paper
• Serum galectin-3 can help distinguish lupus nephritis from systemic lupus erythematosus and is also correlated with the degree of renal damage in lupus nephritis

  2024cites this paper
• Galectin-3 promotes fibrosis in ovarian endometriosis

  2024cites this paper
• Macrophage erythropoietin signaling promotes macrophage-myofibroblast transformation and fibroblast-myofibroblast differentiation.

  2024cites this paper
• Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic Impairment

  2024cites this paper
• Diagnostic Modalities in Heart Failure: A Narrative Review

  2024cites this paper
• Poly-D,L-Lactic Acid Fillers Increase Subcutaneous Adipose Tissue Volume by Promoting Adipogenesis in Aged Animal Skin

  2024cites this paper
• The Possible Effects of Galectin-3 on Mechanisms of Renal and Hepatocellular Injury Induced by Intravascular Hemolysis

  2024cites this paper
• Galectin-3 contributes to pathogenesis of IgA nephropathy.

  2024cites this paper
• Comprehensive Quality Analysis of Conventional and Novel Biomarkers in Diagnosing and Predicting Prognosis of Coronary Artery Disease, Acute Coronary Syndrome, and Heart Failure, a Comprehensive Literature Review

  2024cites this paper
• TRPML-1 Dysfunction and Renal Tubulopathy in Mucolipidosis Type IV

  2024cites this paper
• Heart failure biomarkers in hemodialysis patients

  2024cites this paper
• Galectin-3 inhibition reduces fibrotic scarring and promotes functional recovery after spinal cord injury in mice

  2024cites this paper
• Galectin-3 and soluble CD146 identify cardiorenal injuries in severe burn patients: a biomarker-based approach.

  2024cites this paper
• Understanding Galectin-3’s Role in Diastolic Dysfunction: A Contemporary Perspective

  2024cites this paper
• Chronic kidney disease activates the HDAC6-inflammatory axis in the heart and contributes to myocardial remodeling in mice: inhibition of HDAC6 alleviates chronic kidney disease-induced myocardial remodeling

  2024cites this paper
• Association of suPAR, ST2, and galectin-3 with eGFR decline and mortality in patients with advanced heart failure with reduced ejection fraction

  2024cites this paper
• Targeting Macrophages: Therapeutic Approaches in Diabetic Kidney Disease

  2024cites this paper
• Circulating galectin-3 level association with cardiovascular risk factors during peritoneal dialysis

  2024cites this paper
• Galectin-3: action and clinical utility in chronic kidney disease

  2024cites this paper
• Galectin-3/Gelatin Electrospun Scaffolds Modulate Collagen Synthesis in Skin Healing but Do Not Improve Wound Closure Kinetics

  2024cites this paper
• Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver.

  2024cites this paper
• Monocytes and Macrophages in Kidney Disease and Homeostasis

  2024cites this paper
• Correlations of sST2 and Gal-3 with Cardiothoracic Ratio in Patients with Chronic Kidney Disease

  2024cites this paper
• Modified Citrus Pectin (MCP) Confers a Renoprotective Effect on Early‐Stage Nephropathy in Type‐2 Diabetic Mice

  2024cites this paper
• Faecalibacterium prausnitzii-derived extracellular vesicles alleviate chronic colitis-related intestinal fibrosis by macrophage metabolic reprogramming.

  2024cites this paper
• Exosomes derived from TREM-2 knocked-out macrophages alleviated renal fibrosis via HSPa1b/AKT pathway.

  2024cites this paper
• Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure

  2024cites this paper
• Crosstalk between fibroblasts and immunocytes in fibrosis: From molecular mechanisms to clinical trials

  2024cites this paper
• Galectin-3 in chronic kidney disease.

  2024cites this paper
• Anti-Angiogenic and Anti-Scarring Dual Effect of Galectin-3 Inhibition in Mouse Animal Models of Corneal Wound Healing.

  2023cites this paper
• Galectin-3: therapeutic targeting in liver disease

  2023cites this paper
• Macrophages polarization in renal inflammation and fibrosis animal models (Review)

  2023cites this paper
• An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond

  2023cites this paper
• Galectin-3 Mediates Endotoxin Internalization and Caspase-4/11 Activation in Tubular Epithelials and Macrophages During Sepsis and Sepsis-Associated Acute Kidney Injury

  2023cites this paper
• Fibroblast Growth Factor 2 Is Produced By Renal Tubular Cells to Act as a Paracrine Factor in Maladaptive Kidney Repair After Cisplatin Nephrotoxicity.

  2023cites this paper
• The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target

  2023cites this paper
• Plasma galectin-3 is associated with decreased glomerular filtration rate in chronic HIV

  2023cites this paper
• Cardiac markers and cardiovascular disease in chronic kidney disease.

  2023cites this paper
• Effect of diabetes mellitus on association between galectin‐3 and H2FPEF score in patients with unexplained dyspnea and a preserved left ventricular ejection fraction

  2023cites this paper
• Mechanisms of kidney fibrosis and routes towards therapy.

  2023cites this paper
• Pioglitazone Protects Tubular Epithelial Cells during Kidney Fibrosis by Attenuating miRNA Dysregulation and Autophagy Dysfunction Induced by TGF-β

  2023cites this paper
• A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsia

  2023cites this paper
• Glycomimetics for the inhibition and modulation of lectins

  2023cites this paper
• Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis

  2023cites this paper
• A Novel CD206 Targeting Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice

  2023cites this paper
• Kidney fibrosis: Emerging diagnostic and therapeutic strategies.

  2023cites this paper
• Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases

  2023cites this paper
• Analyses of damage-associated molecular patterns, particularly biglycan, in cisplatin-induced rat progressive renal fibrosis

  2023cites this paper
• Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis

  2023cites this paper
• Role of galectin-3 in cardiac dysfunction induced by subarachnoid hemorrhage.

  2023cites this paper
• Single-cell and spatial transcriptomics identify a macrophage population associated with skeletal muscle fibrosis

  2023cites this paper
• The potential roles of galectin-3 in AKI and CKD

  2023influential citation
• Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants

  2023cites this paper
• The sweet side of wound healing: galectins as promising therapeutic targets in hemostasis, inflammation, proliferation, and maturation/remodeling

  2023cites this paper
• Non-Coding RNAs Regulating Mitochondrial Functions and the Oxidative Stress Response as Putative Targets against Age-Related Macular Degeneration (AMD)

  2023cites this paper
• Unraveling the pathophysiologic role of galectin‐3 in chronically injured liver

  2023cites this paper
• Global research trends in unilateral ureteral obstruction-induced renal fibrosis: A bibliometric and visualized study

  2023cites this paper
• Targeting galectin-driven regulatory circuits in cancer and fibrosis

  2023cites this paper
• Galectin-3 Expression Promotes Pulmonary Hypertension Through Multiple Mechanisms

  2023cites this paper
• Fibrotic diseases

  2022cites this paper
• Three-Dimensional Bio-Printed Autologous Omentum Patch Ameliorates Unilateral Ureteral Obstruction-Induced Renal Fibrosis

  2022cites this paper
• Melatonin ameliorates bleomycin-induced pulmonary fibrosis via activating NRF2 and inhibiting galectin-3 expression

  2022cites this paper
• Proximity labeling technologies to illuminate glycan-protein interactions.

  2022cites this paper
• Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease

  2022cites this paper
• Inhibition of Galectin-3 attenuates silica particles-induced silicosis via regulating the GSK-3β/β-catenin signal pathway-mediated epithelial-mesenchymal transition.

  2022cites this paper
• Biomarkers in Heart Failure: From Research to Clinical Practice

  2022cites this paper